Skip to content

Prospective Cohort Study of the Risk of Recurrent Atrial Fibrillation After Radiofrequency Ablation

Prospective Cohort Study of the Risk of Recurrent Atrial Fibrillation After Radiofrequency Ablation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05638841
Enrollment
300
Registered
2022-12-06
Start date
2023-01-01
Completion date
2026-12-31
Last updated
2024-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Brief summary

In this study, the continuous inclusion of atrial fibrillation patients treated by catheter ablation in the Department of Cardiology, Peking University Third Hospital, through the collection of clinical data and outpatient follow-up, to explore the risk factors of atrial fibrillation recurrence after catheter ablation and the influencing factors of major clinical events in atrial fibrillation patients, and further guide the management mode of atrial fibrillation patients.

Interventions

OTHERAfter radiofrequency ablation of atrial fibrillation

This study imposed an intervention. Clinical data were obtained by telephone or outpatient follow-up.

Sponsors

Peking University Third Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 1\) Age \> 18 * 2\) ECG or holter electrocardiogram confirmed atrial fibrillation

Exclusion criteria

* 1\) Hematological diseases, autoimmune diseases and malignant tumors * 2\) Immobility caused by hemiplegia or severe trauma * 3\) The expected survival time is less than 2 years * 4\) Poor compliance and high risk of expected loss of follow-up * 5\) Disorders of consciousness or Alzheimer's disease

Design outcomes

Primary

MeasureTime frameDescription
Compound cardiovascular event24 monthsStroke, hemorrhage, re-hospitalization for atrial fibrillation and heart failure, and all-cause death

Countries

China

Contacts

Primary ContactYanguang Li, Doctor
liyanguangsuper@163.com+8613693327068
Backup ContactPengxin Xie, master
xiepengxin2014@163.com+8618810793282

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026